FDA Expands Use Of CSL Limited’s Seasonal And H1N1 Vaccines To Infants And Children
The U.S. Food and Drug Administration has approved the use of the CSL Limited’s seasonal and 2009 H1N1 influenza vaccines to include children ages 6 months and older. These vaccine were previously approved for use in adults, ages 18 years and older “Because children are among those most vulnerable to the 2009 H1N1 virus, having a broader range of vaccines available for use in children is an important step in responding to the H1N1 outbreak,” said Margaret A. Hamburg, M.D.
Related Posts
Tags: children, efficacy, expands, h1n1, infants, limiteds, seasonal, vaccines
This entry was posted on Tuesday, November 17th, 2009 at 11:11 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.



